Emerging Role of SGLT-2 Inhibitors for the Treatment of Obesity

ανά Pereira, Maria J., Eriksson, Jan W.
Τόπος έκδοσης Drugs (2019)

Is the Brain a Key Player in Glucose Regulation and Development of Type 2 Diabetes?

ανά Lundqvist, Martin H., Almby, Kristina, Abrahamsson, Niclas, Eriksson, Jan W.
Τόπος έκδοσης Front Physiol (2019)

Novel oral glucose‐lowering drugs are associated with lower risk of all‐cause mortality, cardiovascular events and severe hypoglycaemia compared with insulin in patients with type...

ανά Nyström, Thomas, Bodegard, Johan, Nathanson, David, Thuresson, Marcus, Norhammar, Anna, Eriksson, Jan W.
Τόπος έκδοσης Diabetes Obes Metab (2017)

Calcineurin is an important factor involved in glucose uptake in human adipocytes

ανά Fonseca, Ana Catarina R. G., Carvalho, Eugénia, Eriksson, Jan W., Pereira, Maria J.
Τόπος έκδοσης Mol Cell Biochem (2018)

Dapagliflozin and cardiovascular mortality and disease outcomes in a population with type 2 diabetes similar to that of the DECLARE‐TIMI 58 trial: A nationwide observational study...

ανά Norhammar, Anna, Bodegård, Johan, Nyström, Thomas, Thuresson, Marcus, Nathanson, David, Eriksson, Jan W.
Τόπος έκδοσης Diabetes Obes Metab (2019)

Adipocytes express tissue factor and FVII and are procoagulant in a TF/FVIIa-dependent manner

ανά Edén, Desirée, Panagiotou, Grigorios, Mokhtari, Dariush, Eriksson, Jan W., Åberg, Mikael, Siegbahn, Agneta
Τόπος έκδοσης Ups J Med Sci (2019)

Quality of life after gastric bypass surgery in patients with type 2 diabetes: patients’ experiences during 2 years of follow-up

ανά Katsogiannos, Petros, Randell, Eva, Sundbom, Magnus, Rosenblad, Andreas, Eriksson, Jan W., Leksell, Janeth
Τόπος έκδοσης Diabetol Metab Syndr (2020)

Increased Urine IgM and IgG(2) Levels, Indicating Decreased Glomerular Size Selectivity, Are Not Affected by Dalteparin Therapy in Patients with Type 2 Diabetes

ανά Torffvit, Ole, Kalani, Majid, Apelqvist, Jan, Eliasson, Björn, Eriksson, Jan W., Brismar, Kerstin, Jörneskog, Gun
Έκδοση 2012

Dapagliflozin once‐daily and exenatide once‐weekly dual therapy: A 24‐week randomized, placebo‐controlled, phase II study examining effects on body weight and prediabetes in obese...

ανά Lundkvist, Per, Sjöström, C. David, Amini, Sam, Pereira, Maria J., Johnsson, Eva, Eriksson, Jan W.
Τόπος έκδοσης Diabetes Obes Metab (2016)

Dapagliflozin once daily plus exenatide once weekly in obese adults without diabetes: Sustained reductions in body weight, glycaemia and blood pressure over 1 year

ανά Lundkvist, Per, Pereira, Maria J., Katsogiannos, Petros, Sjöström, C. David, Johnsson, Eva, Eriksson, Jan W.
Τόπος έκδοσης Diabetes Obes Metab (2017)

Healthcare Cost Development in a Type 2 Diabetes Patient Population on Glucose-Lowering Drug Treatment: A Nationwide Observational Study 2006–2014

ανά Nathanson, David, Sabale, Ugne, Eriksson, Jan W., Nyström, Thomas, Norhammar, Anna, Olsson, Urban, Bodegård, Johan
Τόπος έκδοσης Pharmacoecon Open (2017)

Dapagliflozin vs non‐SGLT‐2i treatment is associated with lower healthcare costs in type 2 diabetes patients similar to participants in the DECLARE‐TIMI 58 trial: A nationwide obse...

ανά Norhammar, Anna, Bodegard, Johan, Nyström, Thomas, Thuresson, Marcus, Rikner, Klas, Nathanson, David, Eriksson, Jan W.
Τόπος έκδοσης Diabetes Obes Metab (2019)

A randomised wait-list controlled clinical trial of the effects of acceptance and commitment therapy in patients with type 1 diabetes: a study protocol

ανά Lindholm-Olinder, Anna, Fischier, Johan, Fries, Jenny, Alfonsson, Sven, Elvingson, Veronika, Eriksson, Jan W, Leksell, Janeth
Τόπος έκδοσης BMC Nurs (2015)

Type B insulin resistance syndrome in a patient with type 1 diabetes

ανά Sjöholm, Åke, Pereira, Maria João, Nilsson, Thomas, Linde, Torbjörn, Katsogiannos, Petros, Saaf, Jan, Eriksson, Jan W
Τόπος έκδοσης Endocrinol Diabetes Metab Case Rep (2020)

Quality of life of type 2 diabetes mellitus patients in Ramallah and al-Bireh Governorate–Palestine: a part of the Palestinian diabetes complications and control study (PDCCS)

ανά Tietjen, Anna Katharina, Ghandour, Rula, Mikki, Nahed, Jerdén, Lars, Eriksson, Jan W., Norberg, Margareta, Husseini, Abdullatif
Τόπος έκδοσης Qual Life Res (2021)

Signs of dysregulated fibrinolysis precede the development of type 2 diabetes mellitus in a population-based study

ανά Hernestål-Boman, Jenny, Norberg, Margareta, Jansson, Jan-Hakan, Eliasson, Mats, Eriksson, Jan W, Lindahl, Bernt, Johansson, Lars
Έκδοση 2012

Comparison of four non-alcoholic fatty liver disease detection scores in a Caucasian population

ανά Lind, Lars, Johansson, Lars, Ahlström, Håkan, Eriksson, Jan W, Larsson, Anders, Risérus, Ulf, Kullberg, Joel, Oscarsson, Jan
Τόπος έκδοσης World J Hepatol (2020)

The Plasma Metabolomic Profile is Differently Associated with Liver Fat, Visceral Adipose Tissue, and Pancreatic Fat

ανά Lind, Lars, Salihovic, Samira, Risérus, Ulf, Kullberg, Joel, Johansson, Lars, Ahlström, Håkan, Eriksson, Jan W, Oscarsson, Jan
Τόπος έκδοσης J Clin Endocrinol Metab (2020)

Sleep apnea in men is associated with altered lipid metabolism, glucose tolerance, insulin sensitivity, and body fat percentage

ανά Kamble, Prasad G., Theorell-Haglöw, Jenny, Wiklund, Urban, Franklin, Karl A., Hammar, Ulf, Lindberg, Eva, Eriksson, Jan W.
Τόπος έκδοσης Endocrine (2020)

Altered hormonal and autonomic nerve responses to hypo- and hyperglycaemia are found in overweight and insulin-resistant individuals and may contribute to the development of type 2...

ανά Lundqvist, Martin H., Almby, Kristina, Wiklund, Urban, Abrahamsson, Niclas, Kamble, Prasad G., Pereira, Maria J., Eriksson, Jan W.
Τόπος έκδοσης Diabetologia (2020)